Rhythm Pharmaceuticals, Inc. (RYTM) short interest & options flow
NASDAQRhythm Pharmaceuticals dropped 7.5% on November 3 and is down 6.2% on the week, the sharpest move in months, yet options positioning tells a strikingly different story from the price action. The options signal is the most unusual element of this setup. Traders appear far more bullish than the selloff implies. The put/call ratio collapsed to 0.39 on November 3, nearly three standard…
RYTM retail attention surges 5.4 standard deviations above its own 90-day average, per Wikipedia views and ORTEX stock page traffic data as of October 19.
- Market cap
- $7.67B
- Next earnings
- 23 Feb 2027
Key data as of 5 Nov 2026
Latest signals on RYTM
- Alt Data
RYTM retail attention surges 5.4 standard deviations above its own 90-day average, per Wikipedia views and ORTEX stock page traffic data as of October 19.
RYTM news and analysis
RSSNo long-form analysis yet for RYTM. Pulse alerts and the live data picture are available on ORTEX.
Open RYTM on ORTEX →Want the live picture for RYTM?
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for RYTM — free to start on ORTEX.
Sign up for free →Open RYTM on ORTEX